EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemo‐proteomics in antimalarial target identification and engagement

Brodie L Bailey iD, William Nguyen, Alan F Cowman, Brad E Sleebs iD

Medicinal Research Reviews · 2023-11 · 43 (6) · 2303-2351

DOI: 10.1002/med.21975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 26.05.2023. Verfasst von Brodie L Bailey und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Folic Acid Antagonists. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 291 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Humans have lived in tenuous battle with malaria over millennia. Today, while much of the world is free of the disease, areas of South America, Asia, and Africa still wage this war with substantial impacts on their social and economic development. The threat of widespread resistance to all currently available antimalarial therapies continues to raise concern. Therefore, it is imperative that novel antimalarial chemotypes be developed to populate the pipeline going forward. Phenotypic screening has been responsible for the majority of the new chemotypes emerging in the past few decades. However, this can result in limited information on the molecular target of these compounds which may serve as an unknown variable complicating their progression into clinical development. Target identification and validation is a process that incorporates techniques from a range of different disciplines. Chemical biology and more specifically chemo‐proteomics have been heavily utilized for this purpose. This review provides an in‐depth summary of the application of chemo‐proteomics in antimalarial development. Here we focus particularly on the methodology, practicalities, merits, and limitations of designing these experiments. Together this provides learnings on the future use of chemo‐proteomics in antimalarial development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaFolic Acid AntagonistsHumansProteomicsDrug Resistance

Stichwörter der Autor:innen

antimalarialchemical probemalariatarget engagementtarget identification

Substanzen

AntimalarialsFolic Acid Antagonists

Autor:innen und Institutionen

  • The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Brodie L Bailey, Brad E Sleebs

Zitieren

APA

Bailey, B. L., Nguyen, W., Cowman, A. F., & Sleebs, B. E. (2023). Chemo‐proteomics in antimalarial target identification and engagement. Medicinal Research Reviews, 43(6), 2303-2351. https://doi.org/10.1002/med.21975

Vancouver

Bailey BL, Nguyen W, Cowman AF, Sleebs BE. Chemo‐proteomics in antimalarial target identification and engagement. Medicinal Research Reviews. 2023;43(6):2303-2351. doi:10.1002/med.21975

BibTeX
@article{Bailey2023,
  author = {Bailey, Brodie L and Nguyen, William and Cowman, Alan F and Sleebs, Brad E},
  title = {Chemo‐proteomics in antimalarial target identification and engagement},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {6},
  pages = {2303--2351},
  doi = {10.1002/med.21975}
}
Kostenlos starten →